Impact of medication adherence to dual antiplatelet therapy on the long-term outcome of drug-eluting or bare-metal stents

Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

(2019) Raffaele Piccolo et al.   LANCET

Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain)

(2019) Aida Ribera et al.   BMJ Open

Compliance With Guideline-Directed Medical Therapy in Contemporary Coronary Revascularization Trials

(2018) Ana-Catarina Pinho-Gomes et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)

(2018) Sabato Sorrentino et al.   AMERICAN JOURNAL OF CARDIOLOGY

Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy

(2018) Rahman Shah et al.   JAMA Cardiology

International patterns of dual antiplatelet therapy duration after acute coronary syndromes

(2016) Héctor Bueno et al.   HEART

Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease

(2016) Kaare H. Bønaa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Real-World Evidence — What Is It and What Can It Tell Us?

(2016) Rachel E. Sherman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Thrombotic Complications Associated With Early and Late Nonadherence to Dual Antiplatelet Therapy

(2015) Donald E. Cutlip et al.   JACC-Cardiovascular Interventions

Antiplatelet Therapy Duration Following Bare Metal or Drug-Eluting Coronary Stents

(2015) Dean J. Kereiakes et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-Term Safety of Drug-Eluting and Bare-Metal Stents

(2015) Tullio Palmerini et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials

(2015) Tullio Palmerini et al.   LANCET

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk

(2015) Philip Urban et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-adherence to cardiovascular medications

(2014) K. Kolandaivelu et al.   EUROPEAN HEART JOURNAL

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

(2013) Roxana Mehran et al.   LANCET

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

(2013) S. Bangalore et al.   BMJ-British Medical Journal

Prolonged Clopidogrel Use After Bare Metal and Drug-Eluting Stent Placement

(2012) David P. Faxon et al.   Circulation-Cardiovascular Interventions

Effect of Biolimus-Eluting Stents With Biodegradable Polymer vs Bare-Metal Stents on Cardiovascular Events Among Patients With Acute Myocardial Infarction

(2012) Lorenz Räber et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

(2010) Christoph Kaiser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions

(2008) Somjot S. Brar et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY